Picture of hVIVO logo

HVO — hVIVO News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: hVIVO Announces Shionogi's Positive RSV Antiviral Trial Results

Feb 5 (Reuters) - hVIVO PLC  HVO.L :
    * HVIVO PLC - SHIONOGI REPORTS POSITIVE RESULTS FROM RSV
ANTIVIRAL
HUMAN CHALLENGE TRIAL CONDUCTED BY HVIVO

Source text:  ID:nRSE9106Va 
Further company coverage:  HVO.L 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on hVIVO

See all news